Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Schmidt

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Kidney International|March 29, 2002
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantationLothar Schramm, Mylinh La, Ekkehart Heidbreder, et al.
Systems Medicine (New Rochelle, N.Y.)|May 24, 2019
Time-Resolved Systems Medicine Reveals Viral Infection-Modulating Host TargetsChristian Wiwie, Irina Kuznetsova, Ahmed Mostafa, et al.
Scientific Reports|August 28, 2015
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validationPamela W M Kleikers, Carlijn Hooijmans, Eva Göb, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 18, 2025
Revisiting soluble guanylate cyclase pharmacology: Additive potential of stimulators and activatorsAlexandra Petraina, Mahmoud H Elbatreek, Christopher T Neullens, et al.
Free Radical Biology & Medicine|April 28, 2004
Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen speciesParag Goyal, Norbert Weissmann, Friedrich Grimminger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin IIJulian D Widder, Tomasz J Guzik, Cornelius F H Mueller, et al.
Journal of the American Heart Association|May 15, 2025
Synergistic Network Pharmacology: Preclinical Validation and Clinical Safety in Acute Ischemic StrokeAna I Casas, Cristian Nogales, Rebecca D Szepanowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damageAna I Casas, Eva Geuss, Pamela W M Kleikers, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Kidney International|March 29, 2002
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantationLothar Schramm, Mylinh La, Ekkehart Heidbreder, et al.
Systems Medicine (New Rochelle, N.Y.)|May 24, 2019
Time-Resolved Systems Medicine Reveals Viral Infection-Modulating Host TargetsChristian Wiwie, Irina Kuznetsova, Ahmed Mostafa, et al.
Scientific Reports|August 28, 2015
A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validationPamela W M Kleikers, Carlijn Hooijmans, Eva Göb, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 18, 2025
Revisiting soluble guanylate cyclase pharmacology: Additive potential of stimulators and activatorsAlexandra Petraina, Mahmoud H Elbatreek, Christopher T Neullens, et al.
Free Radical Biology & Medicine|April 28, 2004
Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen speciesParag Goyal, Norbert Weissmann, Friedrich Grimminger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 3, 2007
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin IIJulian D Widder, Tomasz J Guzik, Cornelius F H Mueller, et al.
Journal of the American Heart Association|May 15, 2025
Synergistic Network Pharmacology: Preclinical Validation and Clinical Safety in Acute Ischemic StrokeAna I Casas, Cristian Nogales, Rebecca D Szepanowski, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2017
NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damageAna I Casas, Eva Geuss, Pamela W M Kleikers, et al.
Diabetologia|February 5, 2017
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular diseaseStephen P Gray, Jay C Jha, Kit Kennedy, et al.
Diabetologia|December 3, 2013
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe(-/-) miceE Di Marco, S P Gray, P Chew, et al.
Pageof 17